Hillary Mulder

1.4k total citations
15 papers, 376 citations indexed

About

Hillary Mulder is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hillary Mulder has authored 15 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hillary Mulder's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Hillary Mulder is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Hillary Mulder collaborates with scholars based in United States, Sweden and Italy. Hillary Mulder's co-authors include Tariq Ahmad, G. Michael Felker, Lawrence S. Cohen, Brooke Alhanti, Christopher M. O’Connor, César Caraballo, J. Lindenfeld, James L. Januzzi, Ileana L. Piña and F. Perry Wilson and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Hillary Mulder

11 papers receiving 369 citations

Peers

Countries citing papers authored by Hillary Mulder

Since Specialization

Citations

This map shows the geographic impact of Hillary Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillary Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillary Mulder more than expected).

Fields of papers citing papers by Hillary Mulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillary Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillary Mulder. The network helps show where Hillary Mulder may publish in the future.

Co-authorship network of co-authors of Hillary Mulder

This figure shows the co-authorship network connecting the top 25 collaborators of Hillary Mulder. A scholar is included among the top collaborators of Hillary Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillary Mulder. Hillary Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Antifibrotic Dose Reductions and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis in Real-World Data Sources 2025 ·American Journal of Respiratory and Critical Care Medicine ·Aparna Swaminathan, Susanna R. Stevens, Prem Chopra, Hillary Mulder, Peter Shrader, (unknown), Scott M. Palmer, Lisa Wruck	0
2	Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial 2024 ·BMJ Open ·Guillaume Marquis‐Gravel, Hillary Mulder, Lisa Wruck, Catherine P. Benziger, Mark B. Effron, Peter Farrehi, Saket Girotra, Kamal Gupta, (unknown), Daniel Muñoz, Tamar S. Polonsky, Jeff Whittle, Robert A. Harrington, Russell L. Rothman, Adrian F. Hernandez, (unknown)	0
3	Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes 2023 ·SHILAP Revista de lepidopterología ·Michelle D. Kelsey, Hillary Mulder, Karen Chiswell, (unknown), (unknown), Jacquelyn Kulinski, Parag H. Joshi, W. Schuyler Jones, Alanna M. Chamberlain, Thorsten M. Leucker, Wenke Hwang, M. Wesley Milks, Anuradha Paranjape, Jihad S. Obeid, MacRae F. Linton, Shia T. Kent, Eric D. Peterson, Emily C. O’Brien, Neha J. Pagidipati	22
4	Impact of Prenatal Diagnosis of Critical Congenital Heart Disease on Preoperative and Postoperative Outcomes 2023 ·Pediatric Cardiology ·(unknown), Jennifer S. Li, Hillary Mulder, (unknown), Karen Chiswell, Timothy M. Hoffman, Robert J. Hartman, Michael J. Walsh, Charlie J. Sang, (unknown), (unknown), Karl F. Welke, (unknown), (unknown)	2
5	Circulating prostasin associates with presence and severity of idiopathic pulmonary fibrosis (IPF) 2023 ·Jamie L. Todd, Hillary Mulder, Megan L. Neely, John A. Belperio, Joseph A. Lasky, Tracy Luckhardt, Scott M. Palmer, Christian Heßlinger, Thomas Schlange, Thomas B. Leonard	0
6	A Multivariable Protein-Inclusive Predictor of Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry 2022 ·Jamie L. Todd, Megan L. Neely, Hillary Mulder, Lisa Lancaster, Eric S. White, Christian Heßlinger, (unknown)	0
7	Concordance Between Patient-Reported Health Data and Electronic Health Data in the ADAPTABLE Trial 2022 ·JAMA Cardiology ·Emily C. O’Brien, Hillary Mulder, W. Schuyler Jones, Bradley G. Hammill, (unknown), Adrian F. Hernandez, Lesley H. Curtis	5
8	Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial) 2020 ·The American Journal of Cardiology ·Adam J. Nelson, Ann Marie Návar, Hillary Mulder, Daniel Wojdyla, Sephy Philip, Craig Granowitz, Eric D. Peterson, Neha J. Pagidipati	16
9	Cause of Death Among Patients With Peripheral Artery Disease 2020 ·Circulation Cardiovascular Quality and Outcomes ·Ajar Kochar, Hillary Mulder, Frank W. Rockhold, Iris Baumgärtner, Jeffrey S. Berger, Juuso Blomster, F. Gerry R. Fowkes, Brian G. Katona, Renato D. Lópes, Hussein R. Al‐Khalidi, Kenneth W. Mahaffey, Lars Norgren, William R. Hiatt, Manesh R. Patel, W. Schuyler Jones	20
10	Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors? 2020 ·Circulation Cardiovascular Quality and Outcomes ·Ann Marie Návar, Hillary Mulder, Daniel Wojdyla, Eric D. Peterson	12
11	Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial 2019 ·American Heart Journal ·David García, Deborah A. Fisher, Hillary Mulder, Lisa Wruck, (unknown), Sigrun Halvorsen, Christopher B. Granger, Claes Held, Lars Wallentin, John H. Alexander, Renato D. Lópes	19
12	Influence of Weight Reduction and Enhanced Protein Intake on Biomarkers of Inflammation in Older Adults with Obesity 2019 ·Journal of Nutrition in Gerontology and Geriatrics ·Kathryn N. Porter Starr, Melissa C. Orenduff, Shelley R. McDonald, Hillary Mulder, Richard Sloane, Carl F. Pieper, Connie W. Bales	24
13	Clinical Implications of the New York Heart Association Classification 2019 ·Journal of the American Heart Association ·César Caraballo, Nihar R. Desai, Hillary Mulder, Brooke Alhanti, F. Perry Wilson, Mona Fiuzat, G. Michael Felker, Ileana L. Piña, Christopher M. O’Connor, J. Lindenfeld, James L. Januzzi, Lawrence S. Cohen, Tariq Ahmad	178
14	Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial 2019 ·Circulation ·Frederik Dalgaard, Hillary Mulder, Daniel Wojdyla, Renato D. Lópes, Claes Held, John H. Alexander, Raffaele De Caterina, Jeffrey B. Washam, Elaine M. Hylek, David García, Bernard J. Gersh, Lars Wallentin, Christopher B. Granger, Sana M. Al‐Khatib	30
15	Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial 2018 ·American Heart Journal ·Karen P. Alexander, Marc A. Brouwer, Hillary Mulder, Dragoş Vinereanu, Renato D. Lópes, Marco Proietti, Sana M. Al‐Khatib, Ziad Hijazi, Sigrun Halvorsen, Elaine M. Hylek, Freek W.A. Verheugt, John H. Alexander, Lars Wallentin, Christopher B. Granger	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact